Research
Latest papers
Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro.
British journal of haematology · 2008
Latest funding
- $2,945,248
Functional Outcomes, Lung health, and Livelihood Outcomes among people With Tuberculosis (FOLLOW-TB): a pan-Canadian prospective cohort study
CIHR · 2025 · Principal investigator
- $313,650
Risk Assessment and Determinants of Tuberculosis Associated Respiratory Impairment and Disability (RADAR-TB): A Systematic Review and Individual Participant Data Meta-Analysis
CIHR · 2024 · Principal investigator
- $1,154,425
Finding the right balance: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention (treatment of TB Infection)
CIHR · 2023 · Principal investigator
1 publications.
Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro.
Amrein L, Hernandez TA, Ferrario C, Johnston J, Gibson SB, Panasci L, Aloyz R
Functional Outcomes, Lung health, and Livelihood Outcomes among people With Tuberculosis (FOLLOW-TB): a pan-Canadian prospective cohort study
Principal investigators: Campbell, Jonathon; Brode, Sarah K; Johnston, James C; Law, Stephanie
Keywords: Lung Health; Public Health; Quality Of Life; Sequelae; Tuberculosis
Risk Assessment and Determinants of Tuberculosis Associated Respiratory Impairment and Disability (RADAR-TB): A Systematic Review and Individual Participant Data Meta-Analysis
Principal investigators: Campbell, Jonathon; Johnston, James C
Keywords: Risk-Factors; Risk-Prediction; Sequelae; Tuberculosis
Finding the right balance: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention (treatment of TB Infection)
Principal investigators: Menzies, Richard; Campbell, Jonathon; Fox, Gregory; Golchi, Shirin; Johnston, James C; Law, Stephanie; Long, Richard; Lupien, Andréanne; Ruslami, Rovina
Keywords: Acceptability; Adaptive Trial; Cost-Effectiveness; Multi-Arm Trial; Multicentre Trial; Randomized Trial; Safety; Tolerability; Tuberculosis; Tuberculosis Prevention
Finding the right balance: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention (treatment of TB Infection)
Principal investigators: Menzies, Richard; Campbell, Jonathon; Fox, Gregory; Golchi, Shirin; Johnston, James C; Law, Stephanie; Long, Richard; Lupien, Andréanne; Ruslami, Rovina
Keywords: Acceptability; Adaptive Trial; Cost-Effectiveness; Multi-Arm Trial; Multicentre Trial; Randomized Trial; Safety; Tolerability; Tuberculosis; Tuberculosis Prevention
A Key Step to Eliminating Tuberculosis in Canada: Informing the Implementation and Scale-up of Tuberculosis Preventive Treatment
Principal investigators: Campbell, Jonathon; Brode, Sarah K; Johnston, James C
Keywords: Prevention; Risk-Benefit; Scale-Up Science; Tuberculosis
Tuberculosis in Canada: Modeling to Inform Elimination
Principal investigators: Schwartzman, Kevin; Johnston, James C
Keywords: Cost-Effectiveness; Decision Analysis; Ethics; Migrants; Prediction; Public Health; Screening; Tuberculosis
Computer-aided detection of pulmonary tuberculosis on digital chest x-rays: its role in the detection of active tuberculosis in a high burden setting of low HIV prevalence
Principal investigators: Ahmad Khan, Faiz
Keywords: Chest Radiography; Decision Analysis; Diagnostic Accuracy; Epidemiology; Population Health; Tuberculosis
Tackling the two greatest obstacles to Tuberculosis elimination: Treatment of latent infection and drug resistant disease.
Principal investigators: Menzies, Richard
Keywords: Cost Effectiveness Analysis; Drug Resistance; Infectious Disease Modeling; Latent Tuberculosis; Randomized Trial; Systematic Reviews And Meta-Analyses; Tuberculosis; Tuberculosis Prevention; Tuberculosis Treatment
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.